Northwest Biotherapeutics, Inc. (NWBO) 是一家上市公司 属于 医疗保健 板块，经营于 生物科技 行业. 公司总部位于 Bethesda, MD, 美国. 现任CEO为 Linda F. Powers.
NWBO 拥有 IPO日期为 2001-12-14, 25 名全职员工, 在 Other OTC, 市值为 $308.14M.
Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct, which is in Phase I/II clinical trials to treat inoperable solid tumors. The company was founded in 1996 and is headquartered in Bethesda, Maryland.
